-
1
-
-
33750613056
-
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
-
DOI 10.1515/BC.2006.164, PII BCHM38710111311
-
Tong K. I., Kobayashi A., Katsuoka F., Yamamoto M., Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biological Chemistry 2006 387 10-11 1311 1320 2-s2.0-33750613056 10.1515/BC.2006.164 (Pubitemid 44691409)
-
(2006)
Biological Chemistry
, vol.387
, Issue.10-11
, pp. 1311-1320
-
-
Tong, K.I.1
Kobayashi, A.2
Katsuoka, F.3
Yamamoto, M.4
-
2
-
-
0242721624
-
Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway
-
DOI 10.1128/MCB.23.23.8786-8794.2003
-
Kwak M.-K., Wakabayashi N., Greenlaw J. L., Yamamoto M., Kensler T. W., Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Molecular and Cellular Biology 2003 23 23 8786 8794 2-s2.0-0242721624 10.1128/MCB.23.23.8786-8794.2003 (Pubitemid 37433379)
-
(2003)
Molecular and Cellular Biology
, vol.23
, Issue.23
, pp. 8786-8794
-
-
Kwak, M.-K.1
Wakabayashi, N.2
Greenlaw, J.L.3
Yamamoto, M.4
Kensler, T.W.5
-
3
-
-
0035260034
-
Role of Transcription Factor Nrf2 in the Induction of Hepatic Phase 2 and Antioxidative Enzymes in vivo by the Cancer Chemoprotective Agent, 3H-1, 2-Dithiole-3-thione
-
Kwak M.-K., Itoh K., Yamamoto M., Sutter T. R., Kensler T. W., Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the Cancer chemoprotective agent, 3H-1, 2-Dithiole-3-thione. Molecular Medicine 2001 7 2 135 145 2-s2.0-0035260034 (Pubitemid 33702029)
-
(2001)
Molecular Medicine
, vol.7
, Issue.2
, pp. 135-145
-
-
Kwak, M.-K.1
Itoh, K.2
Yamamoto, M.3
Sutter, T.R.4
Kensler, T.W.5
-
4
-
-
34347392512
-
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury
-
DOI 10.1096/fj.06-7759com
-
Marzec J. M., Christie J. D., Reddy S. P., Jedlicka A. E., Vuong H., Lanken P. N., Aplenc R., Yamamoto T., Yamamoto M., Cho H.-Y., Kleeberger S. R., Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. The FASEB Journal 2007 21 9 2237 2246 2-s2.0-34347392512 10.1096/fj.06-7759com (Pubitemid 47026458)
-
(2007)
FASEB Journal
, vol.21
, Issue.9
, pp. 2237-2246
-
-
Marzec, J.M.1
Christie, J.D.2
Reddy, S.P.3
Jedlicka, A.E.4
Vuong, H.5
Lanken, P.N.6
Aplenc, R.7
Yamamoto, T.8
Yamamoto, M.9
Cho, H.-Y.10
Kleeberger, S.R.11
-
5
-
-
84873336694
-
Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome
-
Xue P., Hou Y., Chen Y., Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 2013 62 845 854
-
(2013)
Diabetes
, vol.62
, pp. 845-854
-
-
Xue, P.1
Hou, Y.2
Chen, Y.3
-
6
-
-
0242329881
-
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
-
DOI 10.1038/ng1248
-
Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D. R., Harada T., Engel J. D., Yamamoto M., Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nature Genetics 2003 35 3 238 245 2-s2.0-0242329881 10.1038/ng1248 (Pubitemid 37363177)
-
(2003)
Nature Genetics
, vol.35
, Issue.3
, pp. 238-245
-
-
Wakabayashi, N.1
Itoh, K.2
Wakabayashi, J.3
Motohashi, H.4
Noda, S.5
Takahashi, S.6
Imakado, S.7
Kotsuji, T.8
Otsuka, F.9
Roop, D.R.10
Harada, T.11
Engel, J.D.12
Yamamoto, M.13
-
7
-
-
84866894408
-
Comprehensive genomic characterization of squamous cell lung cancers
-
Genome Atlas Research Network C
-
Cancer Genome Atlas Research Network, Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012 489 519 525
-
(2012)
Nature
, vol.489
, pp. 519-525
-
-
-
8
-
-
83555173511
-
Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice
-
2-s2.0-83555173511 10.1007/s11095-011-0500-z
-
Clarke J. D., Hsu A., Williams D. E., Dashwood R. H., Stevens J. F., Yamamoto M., Ho E., Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharmaceutical Research 2011 28 12 3171 3179 2-s2.0-83555173511 10.1007/s11095-011-0500-z
-
(2011)
Pharmaceutical Research
, vol.28
, Issue.12
, pp. 3171-3179
-
-
Clarke, J.D.1
Hsu, A.2
Williams, D.E.3
Dashwood, R.H.4
Stevens, J.F.5
Yamamoto, M.6
Ho, E.7
-
9
-
-
77649273792
-
Nrf2 protects against airway disorders
-
2-s2.0-77649273792 10.1016/j.taap.2009.07.024
-
Cho H.-Y., Kleeberger S. R., Nrf2 protects against airway disorders. Toxicology and Applied Pharmacology 2010 244 1 43 56 2-s2.0-77649273792 10.1016/j.taap.2009.07.024
-
(2010)
Toxicology and Applied Pharmacology
, vol.244
, Issue.1
, pp. 43-56
-
-
Cho, H.-Y.1
Kleeberger, S.R.2
-
10
-
-
84862494503
-
The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops
-
Papp D., Lenti K., Modos D., The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops. The FEBS Letters 2012 586 1795 1802
-
(2012)
The FEBS Letters
, vol.586
, pp. 1795-1802
-
-
Papp, D.1
Lenti, K.2
Modos, D.3
|